NEWS
Special Reports
All News
FDA Briefs
Oncology Icons
The Targeted Pulse
CONFERENCES
Conference Coverage
Conference Listing
Data Dialogue with the Oncology Brothers
MEDIA
All Videos
Case-Based Peer Perspectives
Evolving Paradigms in Oncology
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Medical World News
Pivotal Practice Views with the Oncology Brothers
Podcasts
Practice Playbook
Shorts
Video Series
Webinars
PUBLICATIONS
All Publications
Evolving Paradigms
Peers & Perspectives in Oncology
Targeted Therapies in Oncology
More
CASE-BASED ROUNDTABLE
PARTNERS
RESOURCES
CME/CE
Clinical Trials
Events
Precision Medicine Perspectives
Press Releases
Sponsored Content
Treatment Resources
SUBSCRIBE
Scout
Scout
NEWS
CONFERENCES
MEDIA
PUBLICATIONS
CASE-BASED ROUNDTABLE
PARTNERS
RESOURCES
SUBSCRIBE
BRAIN CANCER
BREAST CANCER
HER2 Breast Cancer
COMMUNITY ONCOLOGY PRACTICE
GENITOURINARY CANCERS
Bladder Cancer
Prostate Cancer
Renal Cell Carcinoma
GENOMIC TESTING
Liquid Biopsies
GI CANCERS
Pancreatic Cancer
Colorectal Cancer
Gastric Cancer
GIST
HCC
GYNECOLOGIC CANCERS
Cervical Cancer
Endometrial Cancer
Ovarian Cancer
HEAD & NECK CANCERS
HEMATOLOGY
Bone Marrow & Stem Cell Transplant
IMMUNOTHERAPY
CAR T-Cell Therapy
LEUKEMIAS
AML
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
LUNG CANCER
MET-Targeted Therapy
Small Cell Lung Cancer
Biomarker-Driven Lung Cancer
EGFR+ Lung Cancer
LYMPHOMAS
DLBCL
Follicular Lymphoma
Mantle Cell Lymphoma
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
ONCOLOGY POLICY
SARCOMA
SKIN CANCERS
Melanoma
THYROID CANCERS
Choose Specialty
Spotlight -
Community Oncology Practice
|
Oncology Policy
|
Myeloma
|
CLL
|
Genomic Testing
|
GU Cancers
Advertisement
Evolving NSCLC Treatment Paradigm
EP. 1: Pathology of Stage IV Lung Adenocarcinoma
August 23rd 2018
EP. 2: Molecular Testing in Stage IV Lung Cancer
August 23rd 2018
EP. 3: Emerging Predictive Biomarkers in NSCLC
August 23rd 2018
EP. 4: Frontline Therapy for EGFR Plus NSCLC: Osimertinib's Impact
August 23rd 2018
EP. 5: ALK/ROS1-Rearranged NSCLC: Approaching Therapy
August 23rd 2018
EP. 6: Sequencing Therapy in ALK/ROS1-Rearranged NSCLC
August 23rd 2018
EP. 7: Treatment of BRAF-Mutant NSCLC
August 23rd 2018
EP. 8: Benefit of Pembrolizumab in NSCLC: The KEYNOTE Trials
August 23rd 2018
EP. 9: Chemo-Immunotherapy in NSCLC: The KEYNOTE-189 Trial
August 23rd 2018
EP. 10: IMpower150: Combining VEGF and I-O Therapy in NSCLC
August 23rd 2018
EP. 11: Dual Checkpoint Inhibition in NSCLC: CheckMate-227
August 23rd 2018
EP. 12: Considering Use of I-O Therapy in Driver Mutation NSCLC
August 23rd 2018
EP. 13: Trials of I-O Therapy in Driver Mutation NSCLC
August 23rd 2018
EP. 14: Driver Mutation NSCLC: Combining Targeted and I-O Therapy
August 23rd 2018
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
CLL Treatment Enters a New Era of Targeted Combinations
2
Expanding the Role of Immunotherapy in Lymphoma
3
SurVaxM Improves OS Only in Younger Subgroup in Newly Diagnosed Glioblastoma
4
Psilocybin-Assisted Therapy Aims at Existential Distress in Lung Cancer
5
AI in Precision Oncology: A Paradigm Shift
